Active

Perrigo Belgium

Switched

BE0417132860

Rechtspersoon Public limited company 1 establishment

Gaston Crommenlaan 6, 9050 Gent Groothandel in farmaceutische en medische artikelen

Active for

49 year, 4 months

Financials

Financial year 2025

Worth noting

  • The team shrank two years in a row.

Revenue

€ 44.6 million

▼ 11% vs 2023

Profit

Growing

€ 9.7 million

▲ 53% vs 2023

Debts

Low

€ 14.4 million

▲ 23% vs 2023

Perrigo Belgium from Gent, company number BE0417132860, closed financial year 2025 with a result of € 9.7 million after tax. For that financial year Perrigo Belgium recorded revenue of € 44.6 million and equity of € 514.7 million. Compared with financial year 2023, the result moved from € 6.3 million to € 9.7 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.

What happened at Perrigo Belgium?

What happened at Perrigo Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Ronald van Workum stepped down as director. NBB
  • Magali Verbraeken stepped down as director. NBB
  • Anja van Winsberghe stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 9.7 million (▲ 53% vs 2023). Source: NBB ↗
  • Ronald van Workum became a director. NBB
  • Magali Verbraeken became a director. NBB
  • Anja van Winsberghe became a director. NBB
  • New establishment in Gent. KBO

In short

From € 1 million profit in 2021 to € 9.7 million profit in 2025.

Paid € 3.5 million in corporate taxes since 2021.

Best year ever: 2022, with € 33.6 million profit.

Pays suppliers within 129 days on average.

A new publication or filing at Perrigo Belgium? We notify you, reason included.

Follow Perrigo Belgium

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

The shares are held by Perrigo Capital NV (79.9%) and Perrigo Holding NV (20.1%). It owns 100% of Omega Pharma International, 100% of Omega Pharma Trading, 100% of Medgenix, 100% of Oce Bio and 47.8% of Omega Pharma Manufacturing GmbH & Co. KG itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Magali Verbraeken

Director

Also active at: MEDGENIX BENELUX, OMEGA PHARMA TRADING, Perrigo Capital +5 more

since 2024 · until 2030

Anja van Winsberghe

Director

Also active at: MEDGENIX BENELUX, OMEGA PHARMA TRADING, Perrigo Capital +7 more

since 2023 · until 2029

Ronald van Workum

Director

Also active at: Oce-Bio

since 2025 · until 2031

Shareholders

Participations

Oce Bio

100%

Omega Pharma Manufacturing GmbH & Co. KG

47.8%

Establishments

Establishment units

Physical locations of this company

Registered office

Gaston Crommenlaan 6 box 606

9050 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0417.132.860
VAT number
BE 0417.132.860
Registered office
Gaston Crommenlaan 6 bus 606, 9050 Gent
Names & denominations
Perrigo Belgium
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
5 May 1977
Peppol
Active · Active since 8 Dec 2025
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

Groothandel in andere consumentenartikelen, neg

Overige groothandel in consumentenartikelen, n.e.g.

Detailhandel in vaste, vloeibare en gasvormige brandstoffen, muv motorbrandstoffen

Overige detailhandel, niet in winkels en exclusief markt- en straathandel

Frequently asked questions

What is the enterprise number of Perrigo Belgium?
The enterprise number of Perrigo Belgium is BE0417132860.
What is the address of Perrigo Belgium?
The registered office of Perrigo Belgium is located at Gaston Crommenlaan 6 box 606, 9050 Gent.
When was Perrigo Belgium founded?
Perrigo Belgium was founded on 5 May 1977.
What is the main activity of Perrigo Belgium?
The main activity of Perrigo Belgium is "Groothandel in farmaceutische en medische artikelen" (NACE code 46460).
Does Perrigo Belgium have a website?
No website is currently known for Perrigo Belgium.
How much profit did Perrigo Belgium make in 2025?
Perrigo Belgium posted a profit after taxes of € 9,663,719 in financial year 2025.
What is the revenue of Perrigo Belgium?
In its most recent annual accounts (2025), Perrigo Belgium reported revenue of € 44,569,497.
How many employees does Perrigo Belgium have?
According to the 2025 annual accounts, Perrigo Belgium has 52.5 full-time equivalents (FTE).
Where can I find the annual accounts of Perrigo Belgium?
Perrigo Belgium files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Perrigo Belgium?
According to the 2025 annual accounts, the directors of Perrigo Belgium are: Magali Verbraeken, Anja van Winsberghe, Ronald van Workum.
Who owns Perrigo Belgium?
The shares are held by Perrigo Capital NV (79.9%) and Perrigo Holding NV (20.1%). It owns 100% of Omega Pharma International, 100% of Omega Pharma Trading, 100% of Medgenix, 100% of Oce Bio and 47.8% of Omega Pharma Manufacturing GmbH & Co. KG itself.
Who are the shareholders of Perrigo Belgium?
According to the 2025 annual accounts, the shareholders of Perrigo Belgium are: Perrigo Capital NV (79.9%), Perrigo Holding NV (20.1%).